Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bengt-Åke Bengtsson

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 10, 2013
Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiationMariam Elbornsson, Galina Götherström, Bengt-Åke Bengtsson, et al.
European Journal of Endocrinology|February 10, 2012
Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiencyMariam Elbornsson, Galina Götherström, Ingvar Bosæus, et al.
European Journal of Endocrinology|November 23, 2011
Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiencyMariam Elbornsson, Galina Götherström, Celina Franco, et al.
European Journal of Endocrinology|November 3, 2016
Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiencyMariam Elbornsson, Alexandra Horvath, Galina Götherström, et al.
European Journal of Endocrinology|February 23, 2013
Fifteen years of GH replacement improves body composition and cardiovascular risk factorsMariam Elbornsson, Galina Götherström, Ingvar Bosæus, et al.
European Journal of Endocrinology|June 2, 2017
Muscle strength in patients with acromegaly at diagnosis and during long-term follow-upLaila Füchtbauer, Daniel S Olsson, Bengt-Åke Bengtsson, et al.
European Journal of Endocrinology|October 23, 2016
Life expectancy in patients with pituitary adenoma receiving growth hormone replacementDaniel S Olsson, Penelope Trimpou, Tobias Hallén, et al.
European Journal of Endocrinology|January 10, 2020
Increased number of retinal vessels in acromegalyLaila Füchtbauer, Daniel S Olsson, Eva C Coopmans, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 25, 2020
Effect of growth hormone treatment on circulating levels of NT-proBNP in patients with ischemic heart failureKristjan Karason, Emanuele Bobbio, Christian Polte, et al.
European Journal of Endocrinology|March 30, 2012
Overall and cause-specific mortality in GH-deficient adults on GH replacementRolf C Gaillard, Anders F Mattsson, Ann-Charlotte Akerblad, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 10, 2013
Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiationMariam Elbornsson, Galina Götherström, Bengt-Åke Bengtsson, et al.
European Journal of Endocrinology|February 10, 2012
Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiencyMariam Elbornsson, Galina Götherström, Ingvar Bosæus, et al.
European Journal of Endocrinology|November 23, 2011
Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiencyMariam Elbornsson, Galina Götherström, Celina Franco, et al.
European Journal of Endocrinology|November 3, 2016
Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiencyMariam Elbornsson, Alexandra Horvath, Galina Götherström, et al.
European Journal of Endocrinology|February 23, 2013
Fifteen years of GH replacement improves body composition and cardiovascular risk factorsMariam Elbornsson, Galina Götherström, Ingvar Bosæus, et al.
European Journal of Endocrinology|June 2, 2017
Muscle strength in patients with acromegaly at diagnosis and during long-term follow-upLaila Füchtbauer, Daniel S Olsson, Bengt-Åke Bengtsson, et al.
European Journal of Endocrinology|October 23, 2016
Life expectancy in patients with pituitary adenoma receiving growth hormone replacementDaniel S Olsson, Penelope Trimpou, Tobias Hallén, et al.
European Journal of Endocrinology|January 10, 2020
Increased number of retinal vessels in acromegalyLaila Füchtbauer, Daniel S Olsson, Eva C Coopmans, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 25, 2020
Effect of growth hormone treatment on circulating levels of NT-proBNP in patients with ischemic heart failureKristjan Karason, Emanuele Bobbio, Christian Polte, et al.
European Journal of Endocrinology|March 30, 2012
Overall and cause-specific mortality in GH-deficient adults on GH replacementRolf C Gaillard, Anders F Mattsson, Ann-Charlotte Akerblad, et al.
Pageof 2